Today’s AI Top Pick: ALNY
7/31/2026 · Turnaround screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live ALNY price forecast →
Alnylam Pharmaceuticals is the highest-conviction turnaround buy today because every input aligns: it's the most oversold name in the pool (RSI 23.52, pos_in_21bar_range 0.01% on the daily, 0% weekly, and drawdowns of -28% to -36% across every timeframe), yet the forecast tape and fundamentals are screaming reversal. Kronos bullish_prob = 1.0 and near_term_bullish = 1.0 with multi-timeframe agreement pointing sharply UP: 1h fc +49.8/+50.8/+50.0, 4h fc +47.5/+57.7/+80.1, 1d fc +55.2/+83.8/+71.4, and even the 1wk shows +4.2/+12.2/+10.8 — no timeframe is fighting the trade. Forecast magnitude is the largest in the entire pool. Fundamentals confirm this is a real turnaround, not a value trap: salesYoY +82.57%, ROE 96.94%, EPS next Y +42.56%, PEG 0.26, gross margin 80.83%, and analyst target upside +95.5% with recom 1.67. The market cap is $27.4B (not a micro-cap lottery ticket). Crucially, the news catalyst just landed — Q2 2026 earnings call transcript posted 7/31 and the highlight was 'Amvuttra Surpasses $1B,' a clean fundamental beat right at the moment price is scraping the low of its 21-bar weekly range. That is the setup textbook turnaround entries are made from. Why today rather than wait: ALNY is at 0% of its daily/weekly range with a fresh positive earnings catalyst — the asymmetry is right now, not after a bounce. Compare to alternatives: FICO just gapped down on guidance cut ('worst day in a year'), FUTU has a Hong Kong SFC asset freeze and DOJ probe hanging over it, NOW just announced up to 1K job cuts and shows negative 1h/4h forecasts, TOST has bullish_prob 0 with negative forecasts, and TMDX/FUTU/KTOS are all near the top of their short-term ranges (chase risk). PODD is the cleanest secondary setup but sits mid-range with smaller forecast magnitude. ALNY offers the deepest drawdown + strongest forecast + confirming fundamental catalyst combination in the pool.
- Perf 1Y is -39.5% and price is at 0% of both daily and weekly 21-bar range — a failed bounce could see another leg lower toward $180
- Debt/Equity 2.76 and PE 48.8 leave little room if biotech sentiment sours or Amvuttra momentum decelerates
- Post-earnings gap risk: transcript just dropped 7/31; any negative sell-side reaction Monday could invalidate the setup
- Weekly forecast (+4-12%) is far more modest than daily/4h forecasts (+50-80%) — the multi-TF alignment is directional but not proportional; weekly could cap upside
- Healthcare/biotech beta risk — a broader risk-off tape can override single-name catalysts, and shortFloat 4.34% offers little squeeze fuel
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | ALNY | BUY NOW | 9.2 | Deepest drawdown + largest forecast magnitude + fresh Amvuttra $1B earnings catalyst — the ideal turnaround entry. |
| 2 | PODD | BUY NOW | 8.4 | Clean multi-TF bullish (near_term 1.0), strong fundamentals, healthy setup into Q2 earnings. |
| 3 | TMDX | BUY PULLBACK | 7.8 | Excellent forecasts and margins, but sits near top of short-term range — wait for a pullback to $72. |
| 4 | CALX | BUY NOW | 7.6 | Oversold (pos_in_range 0-2%), fc_mid +50% on daily, strong analyst recom 1.22 and target upside 77%. |
| 5 | MIR | BUY NOW | 7.4 | Deep drawdown with 1d fc +24/+43/+35 and near_term 1.0; recent Q2 earnings call highlighted robust revenue growth. |
| 6 | PDD | BUY PULLBACK | 7.2 | Cheap (fwdPe 7.06, PE 9.53) with profit margin 21.9%, but at 93% of daily range — don't chase. |
| 7 | GRAB | BUY PULLBACK | 6.9 | Strong recom (1.23) and epsNextY +47%, but 1h forecasts flat and insider selling reported this week. |
| 8 | ORCL | BUY PULLBACK | 6.8 | Solid fundamentals (roe 54%, fwdPe 11.7) and strong 1d fc +38/+43, but 1wk forecasts near zero and AI selloff overhang. |
| 9 | KTOS | BUY PULLBACK | 6.7 | Huge forecasts (fc_short +50-59% on 1h/4h) and defense tailwind, but 1wk fc -28 to -42% is a red flag. |
| 10 | PSN | BUY NOW | 6.6 | Deeply oversold (RSI 34, dd -30% on 4h/1d) with 1d fc +15/+51/+42 — multiple analyst Buy reiterations. |
| 11 | TMUS | BUY NOW | 6.4 | Large-cap quality (fwdPe 12.5, roe 18%) with clean bullish TFs and near_term 1.0; smaller magnitude but low risk. |
| 12 | SRAD | WAIT | 6.2 | Strong fundamentals and analyst PT cuts, but near_term_bullish only 0.4 and 1wk forecasts negative. |
| 13 | CELH | BUY PULLBACK | 6.1 | 1d fc +20/+50/+50 and target upside 88%, but pos_in_range 99% on 1h and short float 21% — earnings 8/6 is binary. |
| 14 | MLCO | BUY PULLBACK | 6.0 | Cheap (PE 9.9, PEG 0.37) with weekly fc +33/+43, but sitting at 98% of daily range — chase risk. |
| 15 | STEP | BUY PULLBACK | 5.9 | Strong forecasts (1d fc +6/+23/+22) but negative profit margin and ROE -750; complicated story per Seeking Alpha. |
| 16 | BIRK | WAIT | 5.7 | Fundamentals fine but forecast magnitudes weak and 1wk forecasts negative — no clear catalyst. |
| 17 | ONON | WAIT | 5.6 | Solid fundamentals, but forecasts modest (fc mostly -6 to +18%) and near_term_bullish only 0.4. |
| 18 | SE | WAIT | 5.4 | 1h and 4h fc -12 to -15% short-term, near_term_bullish 0.2 despite good fundamentals. |
| 19 | QTWO | WAIT | 5.3 | RSI 66.5, pos_in_range 100% weekly, and 1h fc -23% — extended and overbought. |
| 20 | PLTR | AVOID | 5.0 | Weekly fc -47/-48% is a red flag despite AI narrative; valuation stretched (PS 56, PE 138). |
| 21 | WING | WAIT | 4.9 | Deep drawdown (-63% 1Y) but salesYoY only 7.6% and PEG 1.41 — turnaround thesis weakest here. |
| 22 | ARES | WAIT | 4.7 | Forecasts near-flat, target upside only 15.7%, and Blue Owl fundraising slowdown headline is a sector caution. |
| 23 | SITE | AVOID | 4.5 | Stifel just downgraded 7/31, weak fundamentals (opMargin 4.9%, salesYoY 3.3%), and PT cuts across the board. |
| 24 | QXO | WAIT | 4.4 | salesYoY 15,198% is an accounting artifact of M&A; negative margins and no earnings visibility. |
| 25 | VST | AVOID | 4.3 | 1wk forecasts -8/-21/-47% and salesYoY -24% — trend deteriorating despite screen pass. |
| 26 | CHWY | WAIT | 4.2 | Fundamentals thin (opMargin 2.6%, profit 2%), forecasts modest, no clear catalyst. |
| 27 | FICO | AVOID | 2.8 | Just posted worst day in 6 years on downside guidance — do not catch this knife today. |
| 28 | FUTU | AVOID | 2.5 | Hong Kong SFC asset freeze and active DOJ probe/class actions — headline risk kills otherwise-great setup. |
| 29 | NOW | AVOID | 2.4 | Up to 1K job cuts announced, near_term_bullish 0, and short-term forecasts -6 to -12%. |
| 30 | TOST | AVOID | 1.8 | bullish_prob 0, near_term 0, RSI 70 at top of range, and all forecasts negative — broken setup. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord